Use and prescribing patterns of incretin-like diabetes drugs in mostly Hispanic/Latino patients with type 2 diabetes

Incretin mimetic prescribing is relatively low among patients in a predominantly Hispanic/Latino population.

• The frequency of incretin mimetic utilization is notably lower in Hispanic/Latino patients compared to other ethnic groups.
• Identifying predictors of incretin mimetic prescribing could help address disparities in treatment.
• The study focuses on a county-funded hospital system serving a majority Hispanic/Latino demographic.

Simplified